The spray could be an alternative for people who are averse to getting injections, or otherwise find it difficult or ...

A nasal spray flu vaccine for people up to 49 will be available for home use starting in the fall of 2025 after the Food and ...

FluMist is the first vaccine to prevent influenza, more commonly known as the flu, that does not need to be administered by a ...

It’s goodbye needles as you can keep the flu away with a nasal spray as the US Food and Drug Administration (FDA) has approved AstraZeneca’s FluMist for home use. It can be self-administered by adults ...

The U.S. Food and Drug Administration (FDA) has approved FluMist for self-administration. On Friday, the FDA announced that ...

US FDA approves AstraZeneca’s needle-free nasal spray, FluMist for self-administration: Cambridge, UK Monday, September 23, 2024, 09:00 Hrs [IST] AstraZeneca, a global, science- ...

In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration.

The US Food and Drug Administration (FDA) has approved AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...

The FDA approved the first flu vaccine that does not have to be administered by a health care provider, but it won’t be available in time for this respiratory virus season.

And now, there’s growing interest in other nasal spray products such as vaccines and even life-saving medications. For years ...

The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in 2003 for individuals between five and 49 years of age. Its approval has ...

The US Food and Drug Administration has approved first self- or caregiver-administered flu vaccine FluMist.FluMist is ...